Short-chain fatty acids stimulate dendrite elongation in dendritic cells by inhibiting histone deacetylase.

Rho family GTPase dendrite elongation dendritic cell histone deacetylase short-chain fatty acid

Journal

The FEBS journal
ISSN: 1742-4658
Titre abrégé: FEBS J
Pays: England
ID NLM: 101229646

Informations de publication

Date de publication:
30 Aug 2023
Historique:
revised: 08 07 2023
received: 27 02 2023
accepted: 29 08 2023
pubmed: 30 8 2023
medline: 30 8 2023
entrez: 30 8 2023
Statut: aheadofprint

Résumé

Dendritic cells activate immune responses by presenting pathogen-derived molecules. The dendrites of dendritic cells contribute to the incorporation of foreign antigens or presenting antigens to T cells. Short-chain fatty acids (SCFAs), such as acetic, propionic, butyric and valeric acids, have many effects on immune responses by activating specific receptors or inhibiting a histone deacetylase (HDAC), although their effect on dendrite formation in dendritic cells is unknown. In the present study, we aimed to investigate the effect of SCFAs on dendrite elongation using a dendritic cell line (DC2.4 cells) and mouse bone marrow-derived dendritic cells. We found that SCFAs induced dendrite elongation. The elongation was reduced by inhibitors of Src family kinase (SFK), phosphatidylinositol-3 kinase (PI3K), Rho family GTPases (Cdc42, Rac1) or actin polymerization, indicating that SCFAs promote dendrite elongation by activating actin polymerization via the SFK/PI3K/Rho family GTPase signaling pathway. We showed that agonists for SCFA receptors GPR43 and GPR109a did not promote dendrite elongation. By contrast, HDAC inhibitors, including trichostatin A, promoted dendrite elongation in DC2.4 cells, and the promoting activity of trichostatin A was decreased by inhibiting the SFK/PI3K/Rho family GTPase signaling pathway or actin polymerization. Furthermore, DC2.4 cells treated with valeric acid showed enhanced uptake of soluble proteins, insoluble beads and Staphylococcus aureus. We also found that treatment with valeric acid enhanced major histocompatibility complex class II-mediated antigen presentation in bone marrow-derived dendritic cells. These results suggest that SCFAs promote dendrite elongation by inhibiting HDAC, stimulating the SFK/PI3K/Rho family pathway and activating actin polymerization, resulting in increased antigen uptake and presentation in dendritic cells.

Identifiants

pubmed: 37646105
doi: 10.1111/febs.16945
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Japan Society for the Promotion of Science
ID : 20K07030
Organisme : Japan Society for the Promotion of Science
ID : 22H02869
Organisme : Japan Society for the Promotion of Science
ID : 22K19435
Organisme : Japan Society for the Promotion of Science
ID : 23K06130
Organisme : Takeda Science Foundation

Informations de copyright

© 2023 Federation of European Biochemical Societies.

Références

Mellman I & Steinman RM (2001) Dendritic cells: specialized and regulated antigen processing machines. Cell 106, 255-258.
Swetman CA, Leverrier Y, Garg R, Gan CH, Ridley AJ, Katz DR & Chain BM (2002) Extension, retraction and contraction in the formation of a dendritic cell dendrite: distinct roles for Rho GTPases. Eur J Immunol 32, 2074-2083.
Luciani C, Hager FT, Cerovic V & Lelouard H (2022) Dendritic cell functions in the inductive and effector sites of intestinal immunity. Mucosal Immunol 15, 40-50.
Mackay DJ & Hall A (1998) Rho GTPases. J Biol Chem 273, 20685-20688.
Bros M, Haas K, Moll L & Grabbe S (2019) RhoA as a key regulator of innate and adaptive immunity. Cell 8, 733.
Taylor MP, Koyuncu OO & Enquist LW (2011) Subversion of the actin cytoskeleton during viral infection. Nat Rev Microbiol 9, 427-439.
Lu M, Xu C, Zhang Q, Wu X, Tang L, Wang X, Wu J & Wu X (2018) Inhibition of p21-activated kinase 1 attenuates the cardinal features of asthma through suppressing the lymph node homing of dendritic cells. Biochem Pharmacol 154, 464-473.
O'Connor K & Chen M (2013) Dynamic functions of RhoA in tumor cell migration and invasion. Small GTPases 4, 141-147.
Govek EE, Newey SE & Van Aelst L (2005) The role of the Rho GTPases in neuronal development. Genes Dev 19, 1-49.
Auer M, Hausott B & Klimaschewski L (2011) Rho GTPases as regulators of morphological neuroplasticity. Ann Anat 193, 259-266.
Sun M, Wu W, Liu Z & Cong Y (2017) Microbiota metabolite short chain fatty acids, GPCR, and inflammatory bowel diseases. J Gastroenterol 52, 1-8.
Cummings JH, Pomare EW, Branch WJ, Naylor CP & Macfarlane GT (1987) Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 28, 1221-1227.
Chambers ES, Morrison DJ & Frost G (2015) Control of appetite and energy intake by SCFA: what are the potential underlying mechanisms? Proc Nutr Soc 74, 328-336.
Nastasi C, Candela M, Bonefeld CM, Geisler C, Hansen M, Krejsgaard T, Biagi E, Andersen MH, Brigidi P, Odum N et al. (2015) The effect of short-chain fatty acids on human monocyte-derived dendritic cells. Sci Rep 5, 16148.
Asarat M, Apostolopoulos V, Vasiljevic T & Donkor O (2016) Short-chain fatty acids regulate cytokines and Th17/Treg cells in human peripheral blood mononuclear cells in vitro. Immunol Invest 45, 205-222.
Vinolo MA, Rodrigues HG, Nachbar RT & Curi R (2011) Regulation of inflammation by short chain fatty acids. Nutrients 3, 858-876.
Martin PM, Ananth S, Cresci G, Roon P, Smith S & Ganapathy V (2009) Expression and localization of GPR109A (PUMA-G/HM74A) mRNA and protein in mammalian retinal pigment epithelium. Mol Vis 15, 362-372.
Li M, van Esch B, Henricks PAJ, Folkerts G & Garssen J (2018) The anti-inflammatory effects of short chain fatty acids on lipopolysaccharide- or tumor necrosis factor alpha-stimulated endothelial cells via activation of GPR41/43 and inhibition of HDACs. Front Pharmacol 9, 533.
Masui R, Sasaki M, Funaki Y, Ogasawara N, Mizuno M, Iida A, Izawa S, Kondo Y, Ito Y, Tamura Y et al. (2013) G protein-coupled receptor 43 moderates gut inflammation through cytokine regulation from mononuclear cells. Inflamm Bowel Dis 19, 2848-2856.
Le Poul E, Loison C, Struyf S, Springael JY, Lannoy V, Decobecq ME, Brezillon S, Dupriez V, Vassart G, Van Damme J et al. (2003) Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J Biol Chem 278, 25481-25489.
Sina C, Gavrilova O, Forster M, Till A, Derer S, Hildebrand F, Raabe B, Chalaris A, Scheller J, Rehmann A et al. (2009) G protein-coupled receptor 43 is essential for neutrophil recruitment during intestinal inflammation. J Immunol 183, 7514-7522.
Singh N, Gurav A, Sivaprakasam S, Brady E, Padia R, Shi H, Thangaraju M, Prasad PD, Manicassamy S, Munn DH et al. (2014) Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity 40, 128-139.
Schilderink R, Verseijden C & de Jonge WJ (2013) Dietary inhibitors of histone deacetylases in intestinal immunity and homeostasis. Front Immunol 4, 226.
Gurav A, Sivaprakasam S, Bhutia YD, Boettger T, Singh N & Ganapathy V (2015) Slc5a8, a Na+−coupled high-affinity transporter for short-chain fatty acids, is a conditional tumour suppressor in colon that protects against colitis and colon cancer under low-fibre dietary conditions. Biochem J 469, 267-278.
Singh N, Thangaraju M, Prasad PD, Martin PM, Lambert NA, Boettger T, Offermanns S & Ganapathy V (2010) Blockade of dendritic cell development by bacterial fermentation products butyrate and propionate through a transporter (Slc5a8)-dependent inhibition of histone deacetylases. J Biol Chem 285, 27601-27608.
Li M, van Esch B, Wagenaar GTM, Garssen J, Folkerts G & Henricks PAJ (2018) Pro- and anti-inflammatory effects of short chain fatty acids on immune and endothelial cells. Eur J Pharmacol 831, 52-59.
Chang PV, Hao L, Offermanns S & Medzhitov R (2014) The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc Natl Acad Sci USA 111, 2247-2252.
Cain RJ & Ridley AJ (2009) Phosphoinositide 3-kinases in cell migration. Biol Cell 101, 13-29.
Neubrand VE, Pedreno M, Caro M, Forte-Lago I, Delgado M & Gonzalez-Rey E (2014) Mesenchymal stem cells induce the ramification of microglia via the small RhoGTPases Cdc42 and Rac1. Glia 62, 1932-1942.
Wang P, Zhang Y, Gong Y, Yang R, Chen Z, Hu W, Wu Y, Gao M, Xu X, Qin Y et al. (2018) Sodium butyrate triggers a functional elongation of microglial process via Akt-small RhoGTPase activation and HDACs inhibition. Neurobiol Dis 111, 12-25.
Arcaro A, Aubert M, Espinosa del Hierro ME, Khanzada UK, Angelidou S, Tetley TD, Bittermann AG, Frame MC & Seckl MJ (2007) Critical role for lipid raft-associated Src kinases in activation of PI3K-Akt signalling. Cell Signal 19, 1081-1092.
Smith NJ, Ward RJ, Stoddart LA, Hudson BD, Kostenis E, Ulven T, Morris JC, Trankle C, Tikhonova IG, Adams DR et al. (2011) Extracellular loop 2 of the free fatty acid receptor 2 mediates allosterism of a phenylacetamide ago-allosteric modulator. Mol Pharmacol 80, 163-173.
Tunaru S, Kero J, Schaub A, Wufka C, Blaukat A, Pfeffer K & Offermanns S (2003) PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect. Nat Med 9, 352-355.
Dadaglio G, Nelson CA, Deck MB, Petzold SJ & Unanue ER (1997) Characterization and quantitation of peptide-MHC complexes produced from hen egg lysozyme using a monoclonal antibody. Immunity 6, 727-738.
Allen PM, Matsueda GR, Haber E & Unanue ER (1985) Specificity of the T cell receptor: two different determinants are generated by the same peptide and the I-Ak molecule. J Immunol 135, 368-373.
Parsons SJ & Parsons JT (2004) Src family kinases, key regulators of signal transduction. Oncogene 23, 7906-7909.
Liang X, Draghi NA & Resh MD (2004) Signaling from integrins to Fyn to Rho family GTPases regulates morphologic differentiation of oligodendrocytes. J Neurosci 24, 7140-7149.
Tan J, McKenzie C, Potamitis M, Thorburn AN, Mackay CR & Macia L (2014) The role of short-chain fatty acids in health and disease. Adv Immunol 121, 91-119.
Yuille S, Reichardt N, Panda S, Dunbar H & Mulder IE (2018) Human gut bacteria as potent class I histone deacetylase inhibitors in vitro through production of butyric acid and valeric acid. PLoS One 13, e0201073.
Davie JR (2003) Inhibition of histone deacetylase activity by butyrate. J Nutr 133, 2485S-2493S.
Roche PA & Furuta K (2015) The ins and outs of MHC class II-mediated antigen processing and presentation. Nat Rev Immunol 15, 203-216.
Bogunovic M, Ginhoux F, Helft J, Shang L, Hashimoto D, Greter M, Liu K, Jakubzick C, Ingersoll MA, Leboeuf M et al. (2009) Origin of the lamina propria dendritic cell network. Immunity 31, 513-525.
Farache J, Koren I, Milo I, Gurevich I, Kim KW, Zigmond E, Furtado GC, Lira SA & Shakhar G (2013) Luminal bacteria recruit CD103+ dendritic cells into the intestinal epithelium to sample bacterial antigens for presentation. Immunity 38, 581-595.
Morita N, Umemoto E, Fujita S, Hayashi A, Kikuta J, Kimura I, Haneda T, Imai T, Inoue A, Mimuro H et al. (2019) GPR31-dependent dendrite protrusion of intestinal CX3CR1(+) cells by bacterial metabolites. Nature 566, 110-114.
Bekiaris V, Persson EK & Agace WW (2014) Intestinal dendritic cells in the regulation of mucosal immunity. Immunol Rev 260, 86-101.
Parada Venegas D, De la Fuente MK, Landskron G, Gonzalez MJ, Quera R, Dijkstra G, Harmsen HJM, Faber KN & Hermoso MA (2019) Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases. Front Immunol 10, 277.
Schwiertz A, Taras D, Schafer K, Beijer S, Bos NA, Donus C & Hardt PD (2010) Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring) 18, 190-195.
McKenzie C, Tan J, Macia L & Mackay CR (2017) The nutrition-gut microbiome-physiology axis and allergic diseases. Immunol Rev 278, 277-295.
Goncalves P, Araujo JR & Di Santo JP (2018) A cross-talk between microbiota-derived short-chain fatty acids and the host mucosal immune system regulates intestinal homeostasis and inflammatory bowel disease. Inflamm Bowel Dis 24, 558-572.
Masaki K, Hiraki Y, Onishi H, Satoh Y, Roche PA, Tanaka S & Furuta K (2020) Ligation of MHC class II induces PKC-dependent Clathrin-mediated endocytosis of MHC class II. Cell 9, 1810.
Shen Z, Reznikoff G, Dranoff G & Rock KL (1997) Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J Immunol 158, 2723-2730.
Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch S, Rueden C, Saalfeld S, Schmid B et al. (2012) Fiji: an open-source platform for biological-image analysis. Nat Methods 9, 676-682.
Benard V, Bohl BP & Bokoch GM (1999) Characterization of rac and cdc42 activation in chemoattractant-stimulated human neutrophils using a novel assay for active GTPases. J Biol Chem 274, 13198-13204.
Furuta K, Walseng E & Roche PA (2013) Internalizing MHC class II-peptide complexes are ubiquitinated in early endosomes and targeted for lysosomal degradation. Proc Natl Acad Sci USA 110, 20188-20193.
Kaito C, Hirano T, Omae Y & Sekimizu K (2011) Digestion of extracellular DNA is required for giant colony formation of Staphylococcus aureus. Microb Pathog 51, 142-148.
Sastalla I, Chim K, Cheung GY, Pomerantsev AP & Leppla SH (2009) Codon-optimized fluorescent proteins designed for expression in low-GC gram-positive bacteria. Appl Environ Microbiol 75, 2099-2110.

Auteurs

Takuho Inamoto (T)

Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama University, Japan.

Kazuyuki Furuta (K)

Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama University, Japan.

Cheng Han (C)

Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama University, Japan.

Mio Uneme (M)

Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama University, Japan.

Tomonori Kano (T)

Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama University, Japan.

Kazuya Ishikawa (K)

Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama University, Japan.

Chikara Kaito (C)

Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama University, Japan.

Classifications MeSH